Johan Vallon-Christersson

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Nature communications

Cancers

NPJ breast cancer

Nature medicine

Lund University Medical Faculty Foundation

Lund University Medical Faculty Foundation (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lund University Medical Faculty Foundation Nov 01 2011

Sweden

Scientist :: Division of Oncology and Pathology

Lund University Medical Faculty Nov 01 2007 - Oct 31 2011

Sweden

Asst. Professor. :: Div. of Oncology

Education History

Lund University Medical Faculty Foundation

Sweden

PHD

Lunds Universitet Naturvetenskapliga fakulteten

Sweden

MSC

Publications

Srinivas Veerla, Lennart Hohmann, Deborah F Nacer, Johan Vallon-Christersson, Johan Staaf
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer. NPJ breast cancer 9 (1) (2023)
Sergio Mosquim Junior, Valentina Siino, Lisa Rydén, Johan Vallon-Christersson, Fredrik Levander
Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery. Cancers 14 (23) (2022)
Sergio Mosquim Junior, Valentina Siino, Lisa Rydén, Johan Vallon-Christersson, Fredrik Levander
Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery. Cancers 14 (23) (2022)
Sergio Mosquim Junior, Valentina Siino, Lisa Rydén, Johan Vallon-Christersson, Fredrik Levander
Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery. Cancers 14 (23) (2022)
Malin Dahlgren, Anthony M George, Christian Brueffer, Sergii Gladchuk, Yilun Chen, Johan Vallon-Christersson, Cecilia Hegardt, Jari Häkkinen, Lisa Rydén, Martin Malmberg, Christer Larsson, Sofia K Gruvberger-Saal, Anna Ehinger, Niklas Loman, Åke Borg, Lao H Saal
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer. JNCI cancer spectrum 5 (2) (2021)
Christer Larsson, Anna Ehinger, Sofia Winslow, Karin Leandersson, Marie Klintman, Ludvig Dahl, Johan Vallon-Christersson, Jari Häkkinen, Cecilia Hegardt, Jonas Manjer, Lao H Saal, Lisa Rydén, Martin Malmberg, Åke Borg, Niklas Loman
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer. NPJ breast cancer 6 (2020)
Helena Persson, Rolf Søkilde, Jari Häkkinen, Johan Vallon-Christersson, Felix Mitelman, Åke Borg, Mattias Höglund, Carlos Rovira
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer. International journal of cancer 146 (12) (2020)
Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese Törngren, Anders Kvist, Markus Ringnér, Inge Marie Svane, Göran Jönsson
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nature communications 11 (1) (2020)
Xavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, Daniel Nebdal, Elin Borgen, Hege Oma Ohnstad, Jon Amund Kyte, Johan Vallon-Christersson, Marie Fongaard, Eldri Undlien Due, Lisa Gregusson Svartdal, My Anh Tu Sveli, Øystein Garred, null null, Arnoldo Frigessi, Kristine Kleivi Sahlberg, Therese Sørlie, Hege G Russnes, Bjørn Naume, Vessela N Kristensen
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nature communications 10 (1) (2019)
Johan Staaf, Dominik Głodzik, Ana Bosch, Johan Vallon-Christersson, Christel Reuterswärd, Jari Häkkinen, Andrea Degasperi, Tauanne Dias Amarante, Lao H Saal, Cecilia Hegardt, Hilary Stobart, Anna Ehinger, Christer Larsson, Lisa Rydén, Niklas Loman, Martin Malmberg, Anders Kvist, Hans Ehrencrona, Helen R Davies, Åke Borg, Serena Nik-Zainal
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nature medicine 25 (10) (2019)
Looket Dihge, Johan Vallon-Christersson, Cecilia Hegardt, Lao H Saal, Jari Häkkinen, Christer Larsson, Anna Ehinger, Niklas Loman, Martin Malmberg, Pär-Ola Bendahl, Åke Borg, Johan Staaf, Lisa Rydén
Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (21) (2019)
Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese Törngren, Anders Kvist, Markus Ringnér, Inge Marie Svane, Göran Jönsson
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nature communications 8 (1) (2017)
Helena Persson, Rolf Søkilde, Jari Häkkinen, Anna Chiara Pirona, Johan Vallon-Christersson, Anders Kvist, Fredrik Mertens, Åke Borg, Felix Mitelman, Mattias Höglund, Carlos Rovira
Frequent miRNA-convergent fusion gene events in breast cancer. Nature communications 8 (1) (2017)

Johan Vallon-Christersson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Johan Vallon-Christersson